SCHEMBL20182283

SCHEMBL20182283

CC(/C(=C/Nc1ccccc1F)N=N)n1cc(C(=N)/C=C\N)c2c(N)ncnc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.36
NTRK3 Q16288 1/20 0.36
NTRK2 Q16620 1/20 0.36
TEK Q02763 4/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
ERBB3 P21860 1/20 0.33
ERBB4 Q15303 1/20 0.33
RET P07949 8/20 0.33
KCNH2 Q12809 1/20 0.32
PDGFRB P09619 1/20 0.32
LCK P06239 4/20 0.32
SRC P12931 3/20 0.32
PDPK1 O15530 3/20 0.32
AKT1 P31749 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
PIK3CG P48736 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182195 0.90 NTRK1 (0.33) NTRK1NTRK3NTRK2TEKEGFR
SCHEMBL20181904 0.81 PDPK1 (0.36) NTRK1NTRK3NTRK2TEKEGFR
SCHEMBL20181907 0.80 EGFR (0.35) NTRK1NTRK3NTRK2TEKEGFR
SCHEMBL20182295 0.79 MTOR (0.33) NTRK1NTRK3NTRK2TEKEGFR
SCHEMBL20182274 0.79 EIF2AK3 (0.40) TEKEGFRRETLCKSRC
SCHEMBL20182362 0.79 CFTR (0.40) TEKEGFRRETLCKSRC
SCHEMBL20182241 0.77 KDR (0.46) TEKEGFRLCKSRCMTOR
SCHEMBL20182343 0.76 ADK (0.31)
SCHEMBL20182231 0.76 NTRK1 (0.44) NTRK1NTRK3NTRK2EGFRRET
SCHEMBL20182228 0.76 KDR (0.45) TEKEGFRLCKSRCMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed